TOPIGEN PHARMACEUTICALS
Topigen Pharmaceuticals is a biotechnology company that is focused on the scientific research and development of therapeutic drugs. It develops treatments for respiratory disorders, including asthma and chronic obstructive pulmonary disease. Topigen Pharmaceuticals offers TPI ASM8, a drug that is developed for the management of moderate to severe asthma; and TPI 1100, a drug that is developed for the chronic obstructive pulmonary disease. Topigen Pharmaceuticals was acquired by Pharmaxis in January 2010. Topigen Pharmaceuticals was founded in 2000 and is based in Montreal, Quebec.
TOPIGEN PHARMACEUTICALS
Industry:
Biotechnology Developer Tools Product Research Therapeutics
Founded:
2000-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.topigen.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
28.6 M CAD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins IPv6 Contact Form 7
Similar Organizations
Jericho Sciences
Jericho Sciences is a focused on research and development of novel antiviral therapeutic and diagnostic products.
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2004-03-25 | Anagenis | Anagenis acquired by Topigen Pharmaceuticals | N/A |
Investors List
Caisse de Depot et Placement du Quebec
Caisse de Depot et Placement du Quebec investment in Series B - Topigen Pharmaceuticals
T2C2 Capital
T2C2 Capital investment in Series B - Topigen Pharmaceuticals
Business Development Bank of Canada
Business Development Bank of Canada investment in Series B - Topigen Pharmaceuticals
Innovatech Grand Montreal
Innovatech Grand Montreal investment in Series B - Topigen Pharmaceuticals
Desjardins Venture Capital
Desjardins Venture Capital investment in Series B - Topigen Pharmaceuticals
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Series B - Topigen Pharmaceuticals
Desjardins Venture Capital
Desjardins Venture Capital investment in Venture Round - Topigen Pharmaceuticals
T2C2 Capital
T2C2 Capital investment in Venture Round - Topigen Pharmaceuticals
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Venture Round - Topigen Pharmaceuticals
Innovatech Grand Montreal
Innovatech Grand Montreal investment in Venture Round - Topigen Pharmaceuticals
Official Site Inspections
http://www.topigen.com
- Host name: 172.67.166.157
- IP address: 172.67.166.157
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Topigen Pharmaceuticals"
Topigen Pharmaceuticals - PitchBook
Topigen Pharmaceuticals General Information Description. Developer of asthma and chronic obstructive pulmonary disorder therapeutics. The company's lead product, TPI-ASM8, is an …See details»
Topigen Pharmaceuticals, Respiratory Research – Th2 lymphocytes …
Synthesis and Assessment of fused β-carboline derivatives as Kappa Opioid Receptor agonist. The synthesis of 5-formyl-6-aryl-6H-indolo[3,2,1-de][1,5] naphthyridine-2-carboxylates by way …See details»
Topigen Pharmaceuticals - Funding, Financials, Valuation & Investors
Mar 25, 2004 TOPIGEN is a biotech company engaged in scientific research and development of novel therapeutic drugs. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Topigen Pharmaceuticals Inc - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Topigen Pharmaceuticals Inc of Montréal, QC. Get the latest business insights from Dun & Bradstreet.See details»
Topigen Pharmaceuticals Inc. - Montreal, Canada - bionity.com
Jan 14, 2010 Topigen Pharmaceuticals offers TPI ASM8, a drug that is developed for the management of moderate to severe asthma; and TPI 1100, a drug that is developed for the …See details»
Topigen Pharmaceuticals - Tech Stack, Apps, Patents & Trademarks
TOPIGEN is a biotech company engaged in scientific research and development of novel therapeutic drugs.See details»
Topigen Pharmaceuticals - Company Profile - Tracxn
Feb 2, 2025 Topigen Pharmaceuticals - Clinical-stage company developing drugs for respiratory disorders. Raised a total funding of $50.1M over 4 rounds from 6 investors. Topigen …See details»
Topigen Pharmaceuticals, Inc.:Company Profile & Technical …
Topigen Pharmaceuticals, Inc. is headquartered in Canada Quebec. Topigen Pharmaceuticals, Inc. was founded in 2000. Topigen Pharmaceuticals, Inc. has a total of 76 patents . Related …See details»
Organization | Topigen Pharmaceuticals Inc.
Organization Overview. First Clinical Trial. 2008 NCT00550797. First Marketed Drug. None First NDA Approval. None Last Known Activity ... Topigen Pharmaceuticals, Montreal, …See details»
Topigen Pharmaceuticals Inc. - BioCentury Company Profiles - BCIQ
Oct 25, 2024 Topigen Pharmaceuticals Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Pharmaxis Ltd. acquires TOPIGEN Pharmaceuticals Inc. - Newswire
Jan 11, 2010 /CNW Telbec/ - TOPIGEN Pharmaceuticals Inc., ... Organization Profile. TOPIGEN PHARMACEUTICALS INC. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET Contact UsSee details»
Topigen Pharmaceuticals - Products, Competitors, Financials, …
Topigen Pharmaceuticals is a company focused on respiratory research within the pharmaceutical industry. The company's main offerings include the development and distribution of various …See details»
Pharmaxis to Acquire Topigen Pharmaceuticals Inc.
Jan 12, 2010 Pharmaxis to Acquire Topigen Pharmaceuticals Inc. MONTREAL--(Marketwire - 01/12/10) - TOPIGEN Pharmaceuticals Inc., a Canadian-based clinical-stage …See details»
Pharmaxis to Take Over Topigen to Pad Pipeline of Respiratory …
Jan 12, 2010 Topigen’s pipeline of drugs is based on its multitargeted oligonucleotide technology. The lead candidate, TPI ASM8, is in Phase II development for the management of …See details»
Topigen Secures Venture Capital Funding | Respiratory Therapy
Aug 15, 2007 Respiratory Therapy. 7300 W 110th St – Floor 7 Overland Park, KS 66210 (913) 955-2600See details»
Topigen Pharmaceuticals - Overview, News & Similar companies
Topigen Pharmaceuticals offers TPI ASM8, a drug that is developed for the management of moderate to severe asthma; and TPI 1100, a drug that is developed for the chronic obstructive …See details»
Topigen Pharmaceuticals Inc.
Jan 1, 2005 Topigen Pharmaceuticals Inc. plans to mount a full-scale attack on chronic respiratory ailments such as asthma, COPD and allergic rhinitis, with mRNA-interfering drugs …See details»
Pharmaxis buys Topigen in all-stock deal - Fierce Biotech
Jan 12, 2010 Australia's Pharmaxis announced today that it plans to acquire Topigen Pharmaceuticals in an all-stock deal. Pharmaxis will issue 3.2 million shares of its stock on …See details»
Topigen Pharmaceuticals, Inc. (Topigen Pharmaceuticals, Inc.) - 药 …
了解Topigen Pharmaceuticals, Inc. (Topigen Pharmaceuticals, Inc.)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 1篇新闻和11篇文献，药物:Nova-21048，ALR-8，TOP …See details»
Organon Acquires TOFIDENCE™ (tocilizumab-bavi), a …
2 days ago Organization: PUB. Release Summary. Organon announced it has acquired regulatory and commercial rights in the U.S. for TOFIDENCE™, a biosimilar to ACTEMRA®, …See details»